Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|February 27, 2018
α-Synuclein Oligomers Induce a Unique Toxic Tau StrainDiana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Urmi Sengupta, et al.
ACS Chemical Neuroscience|October 11, 2013
Design of metastable β-sheet oligomers from natively unstructured peptideMarcos J Guerrero-Muñoz, Diana L Castillo-Carranza, Urmi Sengupta, et al.
Biochemistry|November 5, 2010
Preparation and characterization of neurotoxic tau oligomersCristian A Lasagna-Reeves, Diana L Castillo-Carranza, Marcos J Guerrero-Muoz, et al.
Molecular Neurodegeneration|June 8, 2011
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type miceCristian A Lasagna-Reeves, Diana L Castillo-Carranza, Urmi Sengupta, et al.
Neurochemical Research|April 25, 2012
Differential activation of the ER stress factor XBP1 by oligomeric assembliesDiana L Castillo-Carranza, Yan Zhang, Marcos J Guerrero-Muñoz, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2014
Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seedsDiana L Castillo-Carranza, Julia E Gerson, Urmi Sengupta, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 19, 2012
Identification of oligomers at early stages of tau aggregation in Alzheimer's diseaseCristian A Lasagna-Reeves, Diana L Castillo-Carranza, Urmi Sengupta, et al.
ACS Chemical Neuroscience|October 9, 2015
Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer's DiseaseRiddhi U Bodani, Urmi Sengupta, Diana L Castillo-Carranza, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2015
Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse modelDiana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Urmi Sengupta, et al.
Molecular Neurodegeneration|March 17, 2018
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapyJulia E Gerson, Kathleen M Farmer, Natalie Henson, et al.
Pageof 4